Moderna, a US-based biotech company has claimed that its Coronavirus vaccines are ready for the first tests.
The experimental vaccines have now been shipped just six weeks after it started working on the immunization.
The initial trials of the ‘potential’ vaccine may begin from April, however, it is also expected that the trial and test period can go on for at least a year.
In a statement made by Moderna on Monday claims that that the first batch of its vaccine called mRNA-1273, has been dispatched to the National Institute of Allergy and Infectious Diseases (NIAID).
Moderna also added that the first vials of the experimental vaccine would be used in a planned Phase 1 study in the United States, which typically involves testing a vaccine on a small number of healthy humans.
What’s in mRNA Vaccines?
Moderna has yet to produce a proven vaccine using its mRNA technology platform that aims to make drugs that will help the human body to make proteins to prevent or fight disease.
The drugs will make use of messenger ribonucleic acid, a molecule vital to the proper functioning of the body’s cells.